Cost Optimization Across the Pharma Chain

Q1. Could you start by giving us a brief overview of your professional background, particularly focusing on your expertise in the industry?

I have a broad background that includes work in the pharmaceutical, FMCG, and chemical industries. I began my career in the chemical business before moving into the fast-moving consumer goods (FMCG) sector, where I gained solid experience in supply chain dynamics, production procedures, and product development. Over the years, I transitioned into the pharmaceutical space, where I’ve been focusing more intensively on the manufacturing of drugs, including sterile and non-sterile tropical products, as well as business dynamics. My experience across these industries has given me a comprehensive understanding of both fast-moving product cycles and the stringent quality and regulatory requirements of pharma, allowing me to bring a unique, cross-functional perspective to problem-solving and strategy execution.”

Q2. How are pharmaceutical manufacturers enhancing plant readiness to meet increasingly stringent global regulatory inspections?

Pharmaceutical manufacturers are becoming far more proactive in ensuring inspection readiness — moving from reactive compliance to a culture of continuous readiness. The focus is no longer on preparing for inspections, but on being perpetually audit-ready.

1. Digital Quality Systems: Using QMS, EBR, and MES solutions guarantees data…